Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 42

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 2
Chunk 42
---
,434 $5,164 $6,704 (34)%(23)%Adjusted income from operations$7,741 $7,448 $7,313 4 %2 %Earnings per share (diluted)Shareholders' net income$12.12 $17.39 $21.41 (30)%(19)%Adjusted income from operations$27.33 $25.09 $23.36 9 %7 %Pre-tax adjusted income (loss) from operations by segmentEvernorth Health Services$7,001 $6,442 $6,127 9 %5 %Cigna Healthcare4,229 4,478 4,099 (6)9 Other Operations(9)96 509 N/M(81)Corporate, net of eliminations(1,688)(1,698)(1,466)(1)16 Consolidated pre-tax adjusted income from operations9,533 9,318 9,269 2 1 Income attributable to noncontrolling interests405 146 84 177 74 Net investment (losses) (1)(2,533)(135)(613)N/M(78)Amortization of acquired intangible assets(1,703)(1,819)(1,876)(6)(3)Special items(433)(1,997)1,533 (78)N/MIncome before income taxes$5,269 $5,513 $8,397 (4)%(34)%

(1)Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.

For further analysis and explanation of each segment's results, see the "Segment Reporting" section of this MD&A.

Commentary: 2024 versus 2023

The commentary presented below, and the segment commentaries that follow, compare results for the year ended December 31, 2024 with results for the year ended December 31, 2023. Commentary regarding percentage changes (or bps) and dollar variances represents the driver's impact on the overall category.

Shareholders' net income decreased 34%, or $1,730 million, primarily reflecting increased net